Belarus

Belarus

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.55 (0.47 - 0.63) 2019 Modelled IHME
0.56 (0.48 - 0.63) 2018 Modelled IHME
0.57 (0.49 - 0.65) 2017 Modelled IHME
0.59 (0.50 - 0.67) 2016 Modelled IHME
0.61 (0.50 - 0.70) 2015 Modelled IHME
0.63 (0.52 - 0.72) 2014 Modelled IHME
0.64 (0.54 - 0.73) 2013 Modelled IHME
0.66 (0.56 - 0.75) 2012 Modelled IHME
0.67 (0.57 - 0.76) 2011 Modelled IHME
0.68 (0.59 - 0.79) 2010 Modelled IHME
0.7 (0.61 - 0.80) 2009 Modelled IHME
0.72 (0.62 - 0.82) 2008 Modelled IHME
0.74 (0.63 - 0.84) 2007 Modelled IHME
0.75 (0.65 - 0.87) 2006 Modelled IHME
0.77 (0.66 - 0.89) 2005 Modelled IHME
0.78 (0.66 - 0.89) 2004 Modelled IHME
0.79 (0.67 - 0.90) 2003 Modelled IHME
0.81 (0.68 - 0.91) 2002 Modelled IHME
0.82 (0.68 - 0.93) 2001 Modelled IHME
0.83 (0.69 - 0.94) 2000 Modelled IHME
0.85 (0.71 - 0.95) 1999 Modelled IHME
0.86 (0.73 - 0.97) 1998 Modelled IHME
0.88 (0.75 - 0.99) 1997 Modelled IHME
0.89 (0.76 - 1) 1996 Modelled IHME
0.9 (0.77 - 1.02) 1995 Modelled IHME
0.9 (0.76 - 1.01) 1994 Modelled IHME
0.89 (0.77 - 1.01) 1993 Modelled IHME
0.89 (0.76 - 1) 1992 Modelled IHME
0.88 (0.75 - 0.99) 1991 Modelled IHME
0.87 (0.73 - 0.98) 1990 Modelled IHME
1.94 (0.28 - 11.95) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.04 (0.03 - 0.05) 2019 Modelled IHME
0.04 (0.03 - 0.05) 2018 Modelled IHME
0.04 (0.03 - 0.06) 2017 Modelled IHME
0.04 (0.03 - 0.05) 2016 Modelled IHME
0.04 (0.03 - 0.05) 2015 Modelled IHME
0.04 (0.03 - 0.05) 2014 Modelled IHME
0.04 (0.03 - 0.05) 2013 Modelled IHME
0.05 (0.04 - 0.06) 2012 Modelled IHME
0.05 (0.04 - 0.06) 2011 Modelled IHME
0.05 (0.04 - 0.06) 2010 Modelled IHME
0.05 (0.04 - 0.07) 2009 Modelled IHME
0.06 (0.04 - 0.07) 2008 Modelled IHME
0.06 (0.05 - 0.07) 2007 Modelled IHME
0.06 (0.05 - 0.07) 2006 Modelled IHME
0.06 (0.05 - 0.08) 2005 Modelled IHME
0.07 (0.06 - 0.09) 2004 Modelled IHME
0.09 (0.07 - 0.11) 2003 Modelled IHME
0.12 (0.09 - 0.15) 2002 Modelled IHME
0.16 (0.12 - 0.19) 2001 Modelled IHME
0.2 (0.15 - 0.25) 2000 Modelled IHME
0.3 (0.23 - 0.36) 1999 Modelled IHME
0.47 (0.37 - 0.57) 1998 Modelled IHME
0.65 (0.52 - 0.79) 1997 Modelled IHME
0.8 (0.64 - 0.97) 1996 Modelled IHME
0.86 (0.69 - 1.07) 1995 Modelled IHME
0.86 (0.69 - 1.05) 1994 Modelled IHME
0.86 (0.69 - 1.05) 1993 Modelled IHME
0.85 (0.68 - 1.04) 1992 Modelled IHME
0.83 (0.66 - 1.04) 1991 Modelled IHME
0.81 (0.62 - 1.02) 1990 Modelled IHME
0.2 (0.03 - 1.53) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
19 (14 - 26) 2019 Modelled IHME
19 (14 - 26) 2018 Modelled IHME
19 (14 - 26) 2017 Modelled IHME
19 (14 - 27) 2016 Modelled IHME
19 (14 - 26) 2015 Modelled IHME
20 (14 - 27) 2014 Modelled IHME
20 (14 - 27) 2013 Modelled IHME
20 (14 - 27) 2012 Modelled IHME
20 (14 - 27) 2011 Modelled IHME
20 (14 - 27) 2010 Modelled IHME
20 (14 - 28) 2009 Modelled IHME
21 (15 - 28) 2008 Modelled IHME
21 (15 - 29) 2007 Modelled IHME
22 (16 - 29) 2006 Modelled IHME
22 (16 - 30) 2005 Modelled IHME
22 (16 - 30) 2004 Modelled IHME
22 (16 - 30) 2003 Modelled IHME
22 (16 - 29) 2002 Modelled IHME
21 (15 - 29) 2001 Modelled IHME
21 (15 - 29) 2000 Modelled IHME
21 (15 - 29) 1999 Modelled IHME
21 (15 - 29) 1998 Modelled IHME
21 (15 - 29) 1997 Modelled IHME
22 (15 - 30) 1996 Modelled IHME
22 (15 - 30) 1995 Modelled IHME
22 (15 - 30) 1994 Modelled IHME
22 (15 - 30) 1993 Modelled IHME
22 (15 - 30) 1992 Modelled IHME
22 (16 - 29) 1991 Modelled IHME
22 (16 - 30) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
98 2018 Survey/reported WHO/UNICEF
98 2017 Survey/reported WHO/UNICEF
98 2016 Survey/reported WHO/UNICEF
98 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
98 2012 Survey/reported WHO/UNICEF
98 2011 Survey/reported WHO/UNICEF
98 2010 Survey/reported WHO/UNICEF
98 2009 Survey/reported WHO/UNICEF
98 2008 Survey/reported WHO/UNICEF
98 2007 Survey/reported WHO/UNICEF
99 2006 Survey/reported WHO/UNICEF
99 2005 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
98 2018 Survey/reported WHO/UNICEF
98 2017 Survey/reported WHO/UNICEF
96 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
97 2014 Survey/reported WHO/UNICEF
98 2013 Survey/reported WHO/UNICEF
97 2012 Survey/reported WHO/UNICEF
98 2011 Survey/reported WHO/UNICEF
96 2010 Survey/reported WHO/UNICEF
98 2009 Survey/reported WHO/UNICEF
98 2008 Survey/reported WHO/UNICEF
91 2007 Survey/reported WHO/UNICEF
98 2006 Survey/reported WHO/UNICEF
99 2005 Survey/reported WHO/UNICEF
99 2004 Survey/reported WHO/UNICEF
56 2003 Survey/reported WHO/UNICEF
99 2002 Survey/reported WHO/UNICEF
93 2001 Survey/reported WHO/UNICEF
70 2000 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
27 (16 - 72) 2016 Survey/reported Kecina EA, 2016.
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2005
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
OST in at least one prison
No
NSP in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.18 (1.78 - 2.67) 2019 Modelled IHME
2.17 (1.79 - 2.68) 2018 Modelled IHME
2.18 (1.77 - 2.70) 2017 Modelled IHME
2.19 (1.78 - 2.71) 2016 Modelled IHME
2.22 (1.81 - 2.74) 2015 Modelled IHME
2.24 (1.83 - 2.75) 2014 Modelled IHME
2.27 (1.86 - 2.77) 2013 Modelled IHME
2.29 (1.86 - 2.79) 2012 Modelled IHME
2.3 (1.86 - 2.80) 2011 Modelled IHME
2.31 (1.85 - 2.82) 2010 Modelled IHME
2.3 (1.85 - 2.81) 2009 Modelled IHME
2.29 (1.85 - 2.80) 2008 Modelled IHME
2.28 (1.84 - 2.76) 2007 Modelled IHME
2.26 (1.83 - 2.74) 2006 Modelled IHME
2.23 (1.82 - 2.72) 2005 Modelled IHME
2.21 (1.81 - 2.69) 2004 Modelled IHME
2.18 (1.79 - 2.65) 2003 Modelled IHME
2.15 (1.75 - 2.62) 2002 Modelled IHME
2.12 (1.72 - 2.60) 2001 Modelled IHME
2.08 (1.69 - 2.57) 2000 Modelled IHME
2.05 (1.67 - 2.53) 1999 Modelled IHME
2.01 (1.64 - 2.48) 1998 Modelled IHME
1.97 (1.61 - 2.42) 1997 Modelled IHME
1.94 (1.58 - 2.38) 1996 Modelled IHME
1.93 (1.57 - 2.37) 1995 Modelled IHME
1.92 (1.56 - 2.36) 1994 Modelled IHME
1.91 (1.55 - 2.35) 1993 Modelled IHME
1.9 (1.54 - 2.35) 1992 Modelled IHME
1.9 (1.54 - 2.36) 1991 Modelled IHME
1.9 (1.53 - 2.36) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.3 (0.90 - 2.90) 2014 Modelled Gower et al, 2014
People who inject drugs (PWID)
Download
Value (%) Year Type Source
58.3 (43.30 - 73.30) 2015 Modelled Degenhardt L et al, 2017

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
27 (19 - 35) 2019 Modelled IHME
26 (19 - 34) 2018 Modelled IHME
26 (19 - 34) 2017 Modelled IHME
26 (19 - 34) 2016 Modelled IHME
26 (19 - 33) 2015 Modelled IHME
25 (18 - 33) 2014 Modelled IHME
25 (18 - 33) 2013 Modelled IHME
25 (18 - 32) 2012 Modelled IHME
25 (17 - 32) 2011 Modelled IHME
25 (17 - 32) 2010 Modelled IHME
25 (18 - 32) 2009 Modelled IHME
25 (17 - 32) 2008 Modelled IHME
25 (17 - 32) 2007 Modelled IHME
25 (17 - 32) 2006 Modelled IHME
24 (17 - 32) 2005 Modelled IHME
25 (17 - 33) 2004 Modelled IHME
25 (17 - 33) 2003 Modelled IHME
25 (18 - 33) 2002 Modelled IHME
26 (18 - 34) 2001 Modelled IHME
27 (19 - 35) 2000 Modelled IHME
27 (19 - 35) 1999 Modelled IHME
27 (19 - 36) 1998 Modelled IHME
27 (19 - 36) 1997 Modelled IHME
27 (19 - 36) 1996 Modelled IHME
27 (19 - 36) 1995 Modelled IHME
28 (20 - 36) 1994 Modelled IHME
28 (20 - 36) 1993 Modelled IHME
28 (20 - 37) 1992 Modelled IHME
28 (20 - 37) 1991 Modelled IHME
28 (20 - 36) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 (16 - 72) 2016 Survey/reported Kecina EA, 2016.
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2005
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
OST in at least one prison
No
NSP in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.55 (%)
2019
(0.47 - 0.63(%))
IHME
HCV (RNA/cAg+)
2.18 (%)
2019
(1.78 - 2.67(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
354
2019
(237 - 506)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
497
2019
(339 - 721)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.04 (%)
2019, latest modelled
(0.03 - 0.05(%))
IHME

Prevalence PWID

HCV
58.30 (%)
2015, latest modelled
(43.30 - 73.30(%))
Degenhardt L et al, 2017

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
98 (%)
2018
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
27
2016
(16 - 72)
Kecina EA, 2016.
Eligible for HBV generic medicines
Eligible for HCV generic medicines